Tuesday, December 30, 2025

Samsung Biologics acquires GSK manufacturing facility in Rockville


Some rare good news out of Annapolis about the rare bright spot in the moribund Montgomery County economy: biotech. Samsung Biologics has just acquired the GlaxoSmithKline manufacturing facility in Rockville, Maryland Governor Wes Moore announced yesterday. GSK had announced earlier this year that it would be moving its vaccine research and development operations from that Rockville facility to Massachusetts. Samsung's acquisition will keep more than 500 existing jobs at the site, and add an unspecified number of additional jobs as Samsung adds potential production lines for other local biotech firms in the future.

Moore was hands-on in recruiting the South Korean firm. He personally met with Samsung Biologics executives earlier this year during an international trade and investment mission to Japan and South Korea to promote economic growth and workforce development. 

“We are thrilled that Samsung Biologics has selected Maryland for their first U.S. manufacturing facility, a testament to our state’s leadership in life sciences, our highly-skilled workforce and the commitment of our private and public sector to advance patient health around the globe,” Moore said in a statement Monday. “During our Asia trade mission, we were excited to share with Samsung Biologics executives the many reasons why Maryland is an ideal foothold from which the company can execute its long-term strategy to expand in the U.S. market.”


Montgomery County Executive Marc Elrich, who has targeted life sciences in his efforts to attract high-wage jobs to the County, joined Moore in celebrating the win yesterday. “The acquisition of GSK’s Rockville manufacturing campus by Samsung Biologics represents a significant achievement for Montgomery County,” Elrich said in the statement released by Moore's office. “This $280 million investment brings the world's largest contract drug manufacturer to Montgomery County, ensuring U.S.-based manufacturing continues, safeguarding over 500 current jobs, and setting the stage for further growth as Samsung boosts production capacity. It serves as a robust endorsement of the ecosystem we have cultivated, which is founded on talent, diversity, and enduring partnerships. We proudly welcome Samsung Biologics to Montgomery County, Maryland, and anticipate their contribution in enhancing our economy, workforce, and status as a global life sciences hub.”

No comments:

Post a Comment